Corporate VCs have played a crucial role in financing life sciences companies for decades, but have you ever wondered what, if anything, makes them different from institutional venture capital funds? Join us for this webinar as we talk to a panel of investors at industry-leading CVC funds to learn more about their strategies, investment criteria, and how they measure success.

In this webinar, we'll ask our panelists:

• Are you an independent arm of your Parent company or are you investing off their balance sheet?
• How do you measure success? Is it financial, strategic, or a bit of both?
• Do you prefer to lead investments or come in as part of a syndicate?
• What's the process like to get an investment approved internally? Do you have a traditional investment committee like an institutional VC might?
• Do you require any special rights when you make an investment? Like a Right of First Refusal or Negotiation?
• What do you think is the biggest misconception about CVCs?

Our panelists will be:

• Jason Hafler, Ph.D., Managing Director at Sanofi Ventures
• Rana Al-Hallaq, Ph.D., Senior Director of Worldwide Business Development and Partner at Pfizer Ventures
• Marian Nakada, Ph.D., Vice President of Venture Investments at Johnson & Johnson Innovation

Please send us your questions on corporate venture capital so we can ensure our panelists answer them during the webinar. 

Register here: https://zoom.us/webinar/register/WN_EY_Q9f2yQuaiXuMXkhiltQ